Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Aeglea BioTherapeutics, Inc. Common Stock and Pre-Funded Warrants Offering
Davis Polk advised the joint book-running managers in connection with a $60 million SEC-registered common stock and pre…
Revance Therapeutics, Inc. $115 Million Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $115…
Stemline Therapeutics, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the…
Alnylam Pharmaceuticals, Inc. $387.5 Million Common Stock Offering
Davis Polk advised the sole book-running manager of a $387.5 million SEC-registered offering of 5,000,000 shares of common…
Bristol-Myers Squibb Acquires Celgene
Davis Polk is advising Morgan Stanley & Co. LLC, Evercore and Dyal Co. LLC as financial advisers to Bristol-Myers Squibb…
The Medicines Company $150 Million Convertible Notes Offering
Davis Polk advised the sole initial purchaser in connection with a Rule 144A offering by The Medicines Company of $150…
Hologic, Inc. $3 Billion Senior Secured Credit Facilities Refinancing
Davis Polk advised the administrative agent and the lenders in connection with the refinancing of Hologic, Inc.’s existing…
Secondary Offering of NeoGenomics, Inc. Common Stock
Davis Polk advised the sole book-runner in connection with the SEC-registered secondary offering of 10,835,145 shares of…
Davis Polk Advises Notre Dame Intermédica on Its R$2.7 Billion Equity Offering
Davis Polk advised Notre Dame Intermédica Participações S.A. in connection with the equity offering by Notre Dame…
Davis Polk Advises Nutrisystem on Its Acquisition by Tivity Health
Davis Polk is advising Nutrisystem, Inc. on its $1.4 billion acquisition by Tivity Health, Inc. The transaction, which is…